Publisher
Peertechz Publications Private Limited
Reference42 articles.
1. 1. Harbour R, Miller A (2001) new system for grading recommendations in evidence based guidelines. The Scottish Intercollegiate Guidelines Network Grading Review Group. BMJ 323: 334-336. Link: https://bit.ly/2W9R6qj
2. 2. Burbos N, Morris EP (2011) Menopausal symptoms. BMJ Clin Evid 2011: 0804. Link: https://bit.ly/3AXmdo7
3. 3. Persson I, Yuen J, Bergkvist L, Schairer C (1996) Cancer incidence and mortality in women receiving Estrogen and Estrogen Progestin replacement therapy - long-term follow-up of a Swedish cohort. Int J Cancer 67: 327-332. Link: https://bit.ly/3mcaCO9
4. 4. Collaborative Group on Hormonal factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059. Link: https://bit.ly/37XYGXK
5. 5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. (2002) Risks and benefits of estrogen plus progestin in healthy post-menopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333. Link: https://bit.ly/3AZRYNH